Immunoglobulin M memory B cell decrease in inflammatory bowel disease

European Review for Medical and Pharmacological Sciences

Volumn 8, Issue 5, 2004, Pages 199-203

  Di Sabitino, A ^a   Carsetti, R ^b   Rosado, M M ^b   Ciccocioppo, R ^a   Cazzola, P ^a   Morera, R ^a   Tinozzi, F P ^a   Tinozzi, S ^a   Corazza, G R ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

Author keywords

Crohn's disease; IgM memory B cell; Ulcerative colitis

Indexed keywords

ANTIBIOTIC AGENT; CD19 ANTIGEN; CD22 ANTIGEN; CD27 ANTIGEN; CD38 ANTIGEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN D; IMMUNOGLOBULIN D ANTIBODY; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOGLOBULIN M ANTIBODY; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; LYMPHOCYTE ANTIBODY; MESALAZINE; MONOCLONAL ANTIBODY; STEROID;

ABSCESS; ADULT; AGED; ARTICLE; B LYMPHOCYTE; BLOOD SAMPLING; CELL LINE; CELL SURVIVAL; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; CROHN DISEASE; ENTERITIS; FLOW CYTOMETRY; GERMINAL CENTER; HUMAN; IMMUNE RESPONSE; INFECTION; INFECTION RISK; LYMPHOCYTE DEPLETION; LYMPHOCYTE SUBPOPULATION; MEMORY CELL; PERIPHERAL LYMPHOCYTE; PROTEIN EXPRESSION; SPLEEN; SPLENECTOMY; ULCERATIVE COLITIS;

ADULT; AGED; B-LYMPHOCYTES; BIOLOGICAL MARKERS; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOGLOBULIN M; IMMUNOLOGIC MEMORY; INFLAMMATORY BOWEL DISEASES; LYMPHOCYTE COUNT; MALE; MIDDLE AGED;

EID: 10644249916     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Bouma G, Strober W. The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol 2003; 3: 521-533.
2. Di Sabatino A, Corazza GR. Surviving too long in Crohn's disease. Gut 2001; 49: 6-8.
3. Macdermott RP, Nash GS, Bertovich MJ, et al. Alterations of IgM, IgG, and IgA synthesis and secretion by peripheral blood and intestinal mononuclear cells from patients with ulcerative colitis and Crohn's disease. Gastroenterology 1981; 81: 844-852.
4. Mizoguchi E, Mizoguchi A, Freffer FI, Bhan AK. Regulatory role of mature B-cells in a murine model of inflammatory bowel disease. Int Immunol 2000; 12: 597-605.
5. Mizoguchi A, Mizoguchi E, Smith RN, Freffer FI, Bhan AK. Suppressive role of B cells in chronic colitis of T cell receptor a mutant mice. J Exp Med 1997; 186: 1749-1756.
6. Klein U, Rajewsky K, Kuppers R. Human immunoglobulin (Ig)M+IgD+ peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells. J Exp Med 1998; 188: 1679-1689.
7. Shi Y, Agematsu K, Ochs HD, Sugane K. Functional analysis of human memory B-cell subpopulations: IgD+CD27+ B cells are crucial in secondary immune response by producing high affinity IgM. Clin Immunol 2003; 108: 128-137.
8. Liu YJ, Malisan F, de Bouteilerr O, et al. Within germinal centers, isotype switching of immunoglobulins genes occurs after the onset of somatic mutation. Immunity 1996; 4: 241-250.
9. Kruetzmann S, Rosado MM, Weber H, et al. Human immunoglobulin M memory B cells controlling Streptococcus pneumoniae infections are generated in the spleen. J Exp Med 2003; 197: 939-945.
10. Carsetti R, Rosado MM, Wardemann H. Peripheral development of B cells in mouse and man. Immunol Rev 2004; 197: 179-191.
11. Cucino C, Sonnenberg A. The comorbid occurrence of other diagnosis in patients with ulcerative colitis and Crohn's disease. Am J Gastroenterol 2001; 96: 2107-2112.
12. Best WR, Becktel JM, Singleton JW, Kern F Jr. Development of a Crohn's disease activity index: National Cooperative Crohn's Disease Study. Gastroenterology 1976; 70: 439-444.
13. Rachmilewitz D. Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomized study. BMJ 1989; 298: 82-86.
14. Nitschke L, Carsetti R, Ocker B, Kohler G, Lamers MC. CD22 is a negative regulator of B-cell receptor signalling. Curr Biol 1997; 7: 133-143.
15. Bell SJ, Kamm MA. Review article: the clinical role of anti-TNF-α antibody treatment in Crohn's disease. Aliment Pharmacol Ther 2000; 14: 501-504.
16. Van der Poll T, Keogh CV, Buurman WA, Lowry SF. Passive immunization against tumor necrosis factor-alpha impairs host defense during pneumococcal pneumonia in mice. Am J Respir Crit Care Med 1997; 155: 603-608.
17. Ritz MA, Jost R. Severe pneumococcal pneumonia following treatment with infliximab for Crohn's disease. Inflamm Bowel Dis 2001; 7: 327.
18. Muller AF, Cornford E, Toghill PJ. Splenic function in inflammatory bowel disease: assessment by differential interference microscopy and splenic ultrasound. Q J Med 1993; 86: 333-340.
19. Corazza GR, Gasbarrini G. Defective splenic function and its relation to bowel disease. Clin Gastroenterol 1983; 12: 651-669.
20. Muller AF, Toghill PJ. Hyposplenism in gastrointestinal disease. Gut 1995: 36: 165-167.
21. Dalwadi H, Wei B, Schrage M, Su TT, Rawlings DJ, Braun J. B cell developmental requirement for the Gαi2 gene. J Immunol 2003; 170: 1707-1715.